Microbiome effects on immunity, health and disease in the lung
Shakti D. Shukla(University of Technology Sydney), Philip M. Hansbro(University of Technology Sydney)
Cited by 282
Related Papers
Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2021|198
Animal and translational models of SARS-CoV-2 infection and COVID-19
|Mucosal Immunology|2020|191
Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
|Chemico-Biological Interactions|2022|142
Fibulin-1c regulates transforming growth factor–β activation in pulmonary tissue fibrosis
|JCI Insight|2019|87
Vitamin D—A prominent immunomodulator to prevent <scp>COVID</scp>‐19 infection
|International Journal of Rheumatic Diseases|2022|47